Different responses involving Tfh cells delay parasite-specific antibody production in Trypanosoma cruzi acute

Ana Carolina Leão1,2, Maria Jose Villar1,2, Rakesh Adhikari1,2

  • 1Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.

PubMed

Insights

Mice infected with Trypanosoma cruzi show different immune responses. BALB/c mice had a strong but unspecific antibody response, while C57BL/6 mice had a weaker, more targeted response, aiding parasite clearance.

Area of Science:

  • Immunology
  • Parasitology
  • Infectious Diseases

Background:

  • Chagas disease (CD) affects millions globally, with limited treatment options for chronic infections.
  • Understanding the immune response to *Trypanosoma cruzi* is vital for developing effective vaccines and therapies.

Purpose of the Study:

  • To investigate and compare the T follicular helper (Tfh) and B cell immune responses to *T. cruzi* infection in BALB/c and C57BL/6 mice.
  • To elucidate the role of these responses in parasite-specific antibody production during acute infection.

Main Methods:

  • Infection of female BALB/c and C57BL/6 mice with *T. cruzi* H1 K68 strain.
  • Analysis of splenic Tfh and B cell populations using flow cytometry at 14, 28, and 49 days post-infection.

Main Results:

  • BALB/c mice mounted a Th2-biased response with abundant Tfh and GC B cells, leading to polyclonal B cell activation and hypergammaglobulinemia, but poor parasite clearance.
  • C57BL/6 mice exhibited a Th1-skewed response with "Th1-like Tfh" cells (IFN-γ+, CXCR5+), associated with reduced parasite burden and a more focused antibody response, including parasite-specific IgG2c.

Conclusions:

  • Distinct Tfh cell-mediated immune responses influence B cell activation and antibody production in different mouse models of *T. cruzi* infection.
  • The findings suggest that the "Th1-like Tfh" response in C57BL/6 mice may be more effective in controlling parasite burden despite weaker specific antibody production.
  • This study offers novel insights into Tfh cell dynamics and antibody production in Chagas disease, identifying potential therapeutic targets.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
247
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
70.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
66.3K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
646
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K